Search results
Results From The WOW.Com Content Network
Oblon, McClelland, Maier & Neustadt, L.L.P. (often abbreviated to Oblon) is an intellectual property law firm in Alexandria, Virginia.Founded in 1968 by Norman F. Oblon, [1] Oblon is one of the largest law firms in the United States focusing exclusively on intellectual property law.
The newspaper was founded in 1893 as the Virginia Enterprise and switched names to Mesabi Daily News in 1945. The very first editor of the paper was named R. McGarry, who was succeeded by D. A. Cuppernoll in 1895. [3] In 2014, Adams Publishing group acquired 34 papers, including the Daily News, from American Consolidated Media. [4]
The New Jersey Law Journal (NJLJ) has named the firm Litigation Department of the Year for Intellectual Property in 2022, 2021, 2020, 2019, 2018, 2017, and 2015. U.S. News-Best Law Firms ranked the firm a Tier One in New Jersey for Intellectual Property-Litigation, Litigation-Patent, Patent Law, and Trademark Law in 2023, continuing a decade ...
Ranked #1 in six out of seven IP categories, more than any other law firm. (The Legal 500, 2019) [10] Ranked as a Tier 1 law firm in more than a dozen U.S. and international IP categories. (IAM Patent 1000, 2019) [11] Named “D.C. Intellectual Property Litigation Department of the Year” (The National Law Journal, 2018, 2019) [12]
One of Minnesota's oldest bankruptcy law firms has filed for Chapter 11 bankruptcy protection after losing a five-year legal spat with another bankruptcy law firm over mutual claims of false ...
Ferdinand von Zeppelin in Virginia, June 1863 Ferdinand was the son of Württemberg Minister and Hofmarschall Friedrich Jerôme Wilhelm Karl Graf von Zeppelin (1807–1886) and his wife Amélie Françoise Pauline (born Macaire d'Hogguer) (1816–1852).
The Trump camp’s discussion of expanding the electoral map deeper into the Democratic territory of Minnesota and Virginia comes as Biden’s re-election team says it is eyeing North Carolina ...
(Reuters) -Moderna said on Friday the European Patent Office had upheld the validity of one of the company's key patents, a win in an ongoing COVID-19 vaccine dispute with Pfizer and BioNTech.